Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers-Reference-Cited by-同舟云学术

Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers

Published:2018-04-16 Issue:4 Volume:24 Page:707-716
ISSN:1355-6215
Container-title:Addiction Biology
language:en
Short-container-title:Addiction Biology

Author:

Haney Margaret¹^ORCID,Cooper Ziva D.¹,Bedi Gillinder¹,Herrmann Evan¹,Comer Sandra D.¹,Reed Stephanie Collins¹,Foltin Richard W.¹,Levin Frances R.¹

Affiliation:

1. Division on Substance Use Disorders, New York State Psychiatric Institute and Department of PsychiatryColumbia University Medical Center New York NY USA

Funder

US National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/adb.12621

Reference47 articles.

1. Quantifying the clinical significance of cannabis withdrawal;Allsop DJ;PLoS One,2012

2. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial;Allsop DJ;JAMA Psychiat,2014

3. Novel pharmacologic approaches to treating cannabis use disorder;Balter RE;Curr Addict Rep,2014

4. The current state of pharmacological treatment of Cannabis Use Disorder and withdrawal;Brezing CA;Neuropsychopharm Rev,2018

5. Review of the validity and significance of cannabis withdrawal syndrome;Budney AJ;Am J Psychiatry,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of cannabis use on cigarette smoking cessation in LGBTQ+ individuals.;Psychology of Addictive Behaviors;2024-03-14

2. Guanfacine Treatment in a Patient with Intravenous Buprenorphine/Naloxone Misuse;Case Reports in Psychiatry;2024-01-19

3. Neuroanatomical and neurochemical substrates of addiction;Determinants of Addiction;2023

4. An overview of current pharmacologic interventions for management of cannabis withdrawal syndrome and the evidence for their use;Cannabis Use, Neurobiology, Psychology, and Treatment;2023

5. Substance-Related and Addictive Disorders;Diagnostic and Statistical Manual of Mental Disorders;2022-03-18